These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 39066209)
41. Bacteriophage K1F targets Escherichia coli K1 in cerebral endothelial cells and influences the barrier function. Møller-Olsen C; Ross T; Leppard KN; Foisor V; Smith C; Grammatopoulos DK; Sagona AP Sci Rep; 2020 Jun; 10(1):8903. PubMed ID: 32483257 [TBL] [Abstract][Full Text] [Related]
42. Bacteriophage Adherence to Mucus Mediates Preventive Protection against Pathogenic Bacteria. Almeida GMF; Laanto E; Ashrafi R; Sundberg LR mBio; 2019 Nov; 10(6):. PubMed ID: 31744913 [TBL] [Abstract][Full Text] [Related]
43. Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy. Tagliaferri TL; Jansen M; Horz HP Front Cell Infect Microbiol; 2019; 9():22. PubMed ID: 30834237 [TBL] [Abstract][Full Text] [Related]
44. Oral Phage Therapy of Acute Bacterial Diarrhea With Two Coliphage Preparations: A Randomized Trial in Children From Bangladesh. Sarker SA; Sultana S; Reuteler G; Moine D; Descombes P; Charton F; Bourdin G; McCallin S; Ngom-Bru C; Neville T; Akter M; Huq S; Qadri F; Talukdar K; Kassam M; Delley M; Loiseau C; Deng Y; El Aidy S; Berger B; Brüssow H EBioMedicine; 2016 Feb; 4():124-37. PubMed ID: 26981577 [TBL] [Abstract][Full Text] [Related]
53. The relationship between the phageome and human health: are bacteriophages beneficial or harmful microbes? Fernández L; Duarte AC; Rodríguez A; García P Benef Microbes; 2021 Apr; 12(2):107-120. PubMed ID: 33789552 [TBL] [Abstract][Full Text] [Related]
54. Fluctuating Bacteriophage-induced galU Deficiency Region is Involved in Trade-off Effects on the Phage and Fluoroquinolone Sensitivity in Pseudomonas aeruginosa. Nakamura K; Fujiki J; Nakamura T; Furusawa T; Gondaira S; Usui M; Higuchi H; Tamura Y; Iwano H Virus Res; 2021 Dec; 306():198596. PubMed ID: 34648885 [TBL] [Abstract][Full Text] [Related]
55. Resistance Development to Bacteriophages Occurring during Bacteriophage Therapy. Oechslin F Viruses; 2018 Jun; 10(7):. PubMed ID: 29966329 [TBL] [Abstract][Full Text] [Related]
56. Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going? Luong T; Salabarria AC; Roach DR Clin Ther; 2020 Sep; 42(9):1659-1680. PubMed ID: 32883528 [TBL] [Abstract][Full Text] [Related]
57. Phage-delivered sensitisation with subsequent antibiotic treatment reveals sustained effect against antimicrobial resistant bacteria. Liu H; Li H; Liang Y; Du X; Yang C; Yang L; Xie J; Zhao R; Tong Y; Qiu S; Song H Theranostics; 2020; 10(14):6310-6321. PubMed ID: 32483454 [TBL] [Abstract][Full Text] [Related]
58. A window of opportunity to control the bacterial pathogen Pseudomonas aeruginosa combining antibiotics and phages. Torres-Barceló C; Arias-Sánchez FI; Vasse M; Ramsayer J; Kaltz O; Hochberg ME PLoS One; 2014; 9(9):e106628. PubMed ID: 25259735 [TBL] [Abstract][Full Text] [Related]
59. Enteric-coated bacteriophage tablets for oral administration against gastrointestinal infections. Khanal D; Chang RYK; Hick C; Morales S; Chan HK Int J Pharm; 2021 Nov; 609():121206. PubMed ID: 34673163 [TBL] [Abstract][Full Text] [Related]
60. Bacteriophage adhering to mucus provide a non-host-derived immunity. Barr JJ; Auro R; Furlan M; Whiteson KL; Erb ML; Pogliano J; Stotland A; Wolkowicz R; Cutting AS; Doran KS; Salamon P; Youle M; Rohwer F Proc Natl Acad Sci U S A; 2013 Jun; 110(26):10771-6. PubMed ID: 23690590 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]